GT Biopharma logo
GT Biopharma
GTBP | NASDAQ
Chart Builder DCF Calculator
$3.54
-$0.18 (-4.84%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
+$0.07 (+1.98%)
After-hours: Nov 16, 2026, 6:41 PM ET

GT Biopharma Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – – – – –
– – – – – –
– – – – – –
-12.42M -14.36M -13.58M -21.26M -57.52M -6.76M
123K 402K 780K 292K 38K 3.32K
-28.35M -13.16M -7.6M -20.88M -58.01M -28.3M
-28.35M -13.16M -7.6M -20.88M -58.01M -28.3M
8.95M 8.57M 7.11M 12.45M 47.92M 6.28M
3.47M 5.8M 6.47M 8.81M 9.59M 485K
– – – – – –
12.42M 14.36M 13.58M 21.26M 57.52M 6.76M
127K – 213K 8K 718K 3.32M
– – – – – –
12.42M 14.36M 13.58M 21.26M 57.52M 6.76M
– – – – – –
220.53K 75.88K 53.88K 1.27M 1.13M 175.4K
220.53K 75.88K 53.92K 1.27M 1.13M 175.4K
-156.25 -173.50 -141 -16.50 -51.50 -161.25
-156.25 -173.50 -141 -16.50 -51.50 -161.25
-28.23M -13.16M 5.98M -20.97M -57.48M -24.97M
-28.23M -13.16M -7.6M -20.88M -57.54M -24.98M
– – 13.58M – – 4K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.